Is Retevmo (selpercatinib) available in India?
Retevmo (selpercatinib) availability in India depends on whether it has been granted regulatory approval and whether the manufacturer or its local distribution channel is actively supplying it in the Indian market. The provided information does not specify Retevmo’s current import status, approval status, or commercial availability in India.
What to check if you need Retevmo in India (practically)
Patients and clinicians typically confirm access through:
- The treating oncologist’s contact with the hospital pharmacy or a specialty oncology distributor.
- Whether the drug is listed as available for sale/import through Indian channels.
- Whether any alternate access routes are being used (for example, patient-specific import), which can vary by case and availability.
Is there a cheaper or alternative way to get selpercatinib in India?
If Retevmo itself is not readily available, the practical alternatives in the same therapeutic area are usually:
- Other approved RET inhibitors (depending on indication and availability).
- Any authorized local brands/generics (if and when they exist in India and are approved for the relevant use).
Which options are feasible in India depends on what is approved and what can be supplied to treating centers.
How to get the most accurate, up-to-date answer
Because “availability” changes over time, the fastest way to confirm for your location and indication is to check directly with:
- Your oncologist (they can verify access pathways used by major centers)
- A large oncology hospital pharmacy/distributor in your city
- The manufacturer’s India contact or official distributor (if listed)
If you share your city (or the hospital you’re using) and the indication (NSCLC vs medullary thyroid cancer, etc.), I can narrow what to ask for and what access routes are commonly used.
Sources
No sources were provided in the prompt to verify India availability.